Insider · CIK 0002074748
David Coy Ross
Files at HCAT (Health Catalyst, Inc.). First filing -, latest -.
David Coy Ross files SEC Form 4 as officer at HCAT (Health Catalyst, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Coy Ross has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 1, 2025 | HCAT Health Catalyst, Inc. | 4,793 0.01% of outstanding | $14k | Dec 1, 2025 | $11k |
| Sep 2, 2025 | HCAT Health Catalyst, Inc. | 3,360 0.00% of outstanding | $11k | Sep 2, 2025 | none |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -3,360 | $3.36 | $11k | 204,219 | Sep 4, 2025 |
Questions about David Coy Ross
Answered from the filings on this page, as of the latest one.
Is David Coy Ross buying or selling?
David Coy Ross has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Coy Ross's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Coy Ross has 0.
Where does David Coy Ross file Form 4?
David Coy Ross has filed Form 4 at HCAT (Health Catalyst, Inc.) as Chief Tech & Product Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.